Volume 11, Number 7—July 2005
Stenotrophomonas maltophilia in Salad
Highlight and copy the desired format.
|EID||Qureshi A, Mooney L, Denton M, Kerr KG. Stenotrophomonas maltophilia in Salad. Emerg Infect Dis. 2005;11(7):1157-1158. https://dx.doi.org/10.3201/eid1107.040130|
|AMA||Qureshi A, Mooney L, Denton M, et al. Stenotrophomonas maltophilia in Salad. Emerging Infectious Diseases. 2005;11(7):1157-1158. doi:10.3201/eid1107.040130.|
|APA||Qureshi, A., Mooney, L., Denton, M., & Kerr, K. G. (2005). Stenotrophomonas maltophilia in Salad. Emerging Infectious Diseases, 11(7), 1157-1158. https://dx.doi.org/10.3201/eid1107.040130.|
To the Editor: Stenotrophomonas maltophilia has emerged as an important nosocomial pathogen, especially in debilitated and immunocompromised persons (1). However, comparatively little is known of the epidemiology of this bacterium, and sources and routes of transmission of S. maltophilia are not well understood. The bacterium is widely distributed in the environment, including in plant rhizospheres (2). Although environmental sources such as ice-making machines have been implicated in outbreaks of nosocomial S. maltophilia sepsis, the source of infection in other outbreaks and in sporadic cases often remains unidentified. Food as a source of the bacterium has not been investigated; given the association of the bacterium with plants, we investigated the prevalence of the bacterium in salad vegetables.
Salads were purchased from reputable supermarkets and transported immediately to the laboratory. Ten grams of salad was homogenized in 90-mL sterile saline in a stomacher for 1 to 2 min. Aliquots (200 μL) of decimal dilutions of the homogenate were plated onto vancomycin-imipenem-amphotericin B (VIA) agar (3) and incubated for 24 to 48 h at 30°C. Occasional imipenem-resistant environmental bacteria, such as Janthinobacterium lividum or vancomycin-resistant Enterococcus faecium, may grow on VIA, but the medium contains a mannitol/bromothymol blue indicator system, allowing these bacteria, which produce acid from mannitol, to be distinguished from S. maltophilia. Putative S. maltophilia colonies were further identified by the API 20NE system (bioMérieux, Marcy l'Etoile, France).
Susceptibilities of 9 confirmed isolates to ceftazidime, chloramphenicol, colistin sulfate, gentamicin, minocycline, piperacillin/tazobactam, and trimethoprim-sulfamethoxazole were determined by using a disk diffusion method. Pseudomonas aeruginosa (NCTC10662) was used as a control. Because disk diffusion is not a reliable method for determining the susceptibility of S. maltophilia to quinolone antimicrobial agents (1), the Etest was used.
S. maltophilia was cultured from 14 (78%) of 18 salads. Numbers ranged from 1.50 × 102 to 1.96 × 105 CFU/g (mean 1.75 × 105 CFU/g, median 7.05 × 103 CFU/g). All isolates were susceptible to ciprofloxacin, colistin sulfate, minocycline, and trimethoprim-sulfamethoxazole. Eight (89%) were resistant to chloramphenicol; 7 (78%) to piperacillin/tazobactam; 5 (56%) to ceftazidime, and 2 (22%) to gentamicin.
All products examined were labeled "washed and ready to eat," and, thus, consumers would be unlikely to wash these products before consumption. The growth characteristics of S. maltophilia in products of this type, especially if subject to temperature abuse, are unknown, but in the domestic setting, numbers of the bacterium may increase before use.
All of the 9 isolates examined exhibited resistance to >2 of the 8 agents tested, with 2 isolates resistant to 4 compounds and thus had resistance phenotypes similar to those of strains associated with human infection. These findings are in agreement with those of Berg (2), who reported multiple resistances among isolates of S. maltophilia associated with oilseed rape. However, as with most strains of clinical origin, all the isolates tested here remained susceptible to trimethoprim-sulfamethoxazole and minocycline.
Although other investigators have examined salad products for the prevalence of pathogenic bacteria (4), they did not attempt to isolate S. maltophilia. Another study may have underestimated the prevalence of the bacterium in these products since a selective medium was not used (5). We have shown in a clinical setting that the use of a medium selective for S. maltophilia improves the recovery of this bacterium (6). Furthermore, the optimal growth temperature of S. maltophilia is 30°C, and incubation at higher temperatures (7) may reduce the likelihood of recovering the bacterium from food products. We recommend that future studies of S. maltophilia in food products use a medium such as VIA and that cultures be incubated at 30°C.
Prepackaged, ready-to-eat salads, such as those examined in this study, are washed in chlorinated water before sale. This measure is clearly insufficient to remove S. maltophilia from these items, possibly because the bacterium may exist in biofilms in some of the components of these products. S. maltophilia is capable of forming biofilms on a number of materials (8). Alternatively, products may become contaminated from environmental sources in production plants after washing.
The importance of S. maltophilia in ready-to-eat salads, which are marketed in a manner that assumes the product does not need washing before consumption, is unknown; nevertheless the presence of the bacterium in these products serves to highlight recommendations that these items should be avoided by severely immunocompromised persons, especially those with neutropenia (9). Recently, Apisarnthanarak et al. (10), in a prospective study of hospitalized oncology patients, identified intestinal colonization with S. maltophilia in 4 (9.5%) of 41 patients, which emphasizes that foodstuffs may be a potential source of this bacterium for some patients. This is a preliminary study, however, and further studies are needed, in particular, molecular typing of food and human-associated isolates, to investigate the hypothesis that intestinal carriage of S. maltophilia may follow consumption of contaminated foodstuffs.
- Denton M, Kerr KG. Microbiological and clinical aspects of infections associated with Stenotrophomonas maltophilia. Clin Microbiol Rev. 1998;11:57–80.
- Berg G, Marten P, Ballin G. Stenotrophomonas maltophilia in the rhizosphere of oilseed rape—occurrence, characterization and interaction with phytopathogenic fungi. Microbiol Res. 1996;151:19–27.
- Kerr KG, Denton M, Todd N, Corps CM, Kumari P, Hawkey PM. A new selective differential medium for isolation of Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis. 1996;15:607–10.
- Lin C, Fernando SY, Wei C. Occurrence of Listeria monocytogenes, Salmonella spp., Escherichia coli and E. coli O157:H7 in vegetable salads. Food Contr. 1996;7:135–40.
- Denis C, Picoche B. Microbiologie des legumes frais predecoupes. Industrielle Alimentaire Agricoles. 1986;103:547–53.
- Denton M, Hall MJ, Todd NJ, Kerr KG, Littlewood JM. Improved isolation of Stenotrophomonas maltophilia from sputa of patients with cystic fibrosis using a selective medium. Clin Microbiol Infect. 2000;6:397–8.
- Hagenmaier RD, Baker RA. A survey of the microbial population and ethanol content of bagged salad. J Food Prot. 1998;61:357–9.
- Leriche V, Sibille P, Carpentier B. Use of an enzyme-linked lectinosorbent assay to monitor the shift in polysaccharide composition in bacterial biofilms. Appl Environ Microbiol. 2000;66:1851–6.
- Heard G. Microbial safety of ready-to-eat salads and minimally processed vegetables and fruits. Food Sci Technol Today. 2000;14:15–21.
- Apistharnthanarak A, Fraser VJ, Dunne WM, Little JR, Hoppe-Bauer J, Mayfield JL, Stenotrophomonas maltophilia intestinal colonization in hospitalized oncology patients with diarrhoea. Clin Infect Dis. 2003;37:1131–5.
Please use the form below to submit correspondence to the authors or contact them at the following address:
Kevin G. Kerr, Department of Microbiology, Harrogate and District NHS Foundation Trust, Harrogate HG2 7SX, UK; fax: +44-1423-553077
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: April 23, 2012
- Page last updated: April 23, 2012
- Page last reviewed: April 23, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)